Detalhe da pesquisa
1.
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.
Trials
; 24(1): 773, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38037119
2.
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
Trials
; 22(1): 651, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563240
3.
Introducing new and repurposed TB drugs: the endTB experience.
Int J Tuberc Lung Dis
; 24(10): 1081-1086, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33126943
4.
Setting up pharmacovigilance based on available endTB Project data for bedaquiline.
Int J Tuberc Lung Dis
; 24(10): 1087-1094, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33126944
5.
Is 6 months of bedaquiline enough? Results from the compassionate use of bedaquiline in Armenia and Georgia.
Int J Tuberc Lung Dis
; 22(7): 766-772, 2018 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29914602